Ethyl 2- (3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161798-01-2 Dị Ọcha>99.0% Febuxostat Ụlọ Ọrụ etiti
Ruifu Chemical Supply Febuxostat emetụtara Intermediates:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Ethyl 2- (3-Cyano-4-Hydroxyphenyl) -4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2- (3-Cyano-4-Isobutoxyphenyl) -4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2- (3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161798-01-2
Ethyl 2- (3-Formyl-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161798-03-4
Ethyl 2- (4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Aha Chemical | Ethyl 2- (3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate. |
Ụdị okwu | 2- (3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylic Acid Ethyl Ester;Febuxostat Intermediate |
Nọmba CAS | 161798-01-2 |
Nọmba CAT | RF-PI1111 |
Ọnọdụ Ahịa | N'ọkwa, Mpụta Ihe ruru Tọn |
Usoro ihe omimi | C14H13NO4S |
Ibu molekụla | 291.32 |
Ebe Na-agbaze | 113.0 ruo 117.0 ℃ |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | Ntụ ntụ edo edo na-acha odo odo |
Solubility | 1.0g sample nwere ike etisasịwo na 30ml dichloromethane na dimethyl sulfoxide. |
Nchọpụta UV | Ntinye kachasị na 260nm± 3nm na 321nm± 3nm ogologo ikuku. |
Mmiri (KF) | ≤0.50% |
Ihe fọdụrụ na mgbanye | ≤0.50% |
Otu adịghị ọcha amaghi ama | ≤0.50% |
Mgbakọta adịghị ọcha | ≤1.0% |
Ụzọ ịdị ọcha / nyocha | ≥99.0% (gbakọọ na anhydrous ndabere) |
Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
Ojiji | Ọkara nke Febuxostat (CAS: 144060-53-7) |
ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri
Ethyl 2- (3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate (CAS: 161798-01-2) bụ etiti nke Febuxostat (CAS: 144060-53-7).Febuxostat bụ ọgbọ ọhụrụ xanthine oxidase inhibitor mepụtara site na Tejin Co. (Japan,) nke a na-eji ọgwụ eme ihe maka ọgwụgwọ ogologo oge nke hyperuicemia (gout,) ihe ọhụrụ na-arụ ọrụ nke ọma na-abụghị purine oxidase inhibitor nke xanthine oxidase.A naghị atụ aro ya maka ndị ọrịa gout na-enweghị hyperuricemia.